Application of new guidelines for diagnosing heart failure after myocardial infarction: opinion on a problem
https://doi.org/10.15829/1560-4071-2026-6756
EDN: YLTJCM
Abstract
In the absence of templates of formulating clinical diagnoses of HF after discharge from the hospital in the Russian Ministry of Health’s clinical guidelines for ST-elevation myocardial infarction (MI), non-ST-elevation acute coronary syndrome, and heart failure (CHF), this article proposes various options for formulating a HF diagnosis during this period. The guidelines are based on the new 2024 classification of HF by the Russian Society of Cardiology, which distinguishes between pre-HF and newly diagnosed HF, the diagnosis of which should be established starting 29 days after the index MI.
About the Authors
S. S. Yakushin
Ryazan State Medical University
Russian Federation
Competing Interests:
Russian Federation
Sergey S. Yakushin.
Vysokovoltnaya str., 9, Ryazan, 390026
Competing Interests:
None
O. L. Barbarash
Research Institute for Complex Issues of Cardiovascular Diseases
Russian Federation
Competing Interests:
Russian Federation
Olga L. Barbarash.
Acad. L.S. Barbarash Boulevard, 6, Kemerovo, 650001
Competing Interests:
None
V. Yu. Mareev
Lomonosov Moscow State University
Russian Federation
Competing Interests:
Russian Federation
Vyacheslav Yu. Mareev.
Leninskie gory, 1, Moscow
Competing Interests:
None
D. V. Duplyakov
Polyakov Samara Regional Clinical Cardiology Dispensary; Institute of Professional Education, Samara State Medical University
Russian Federation
Competing Interests:
Russian Federation
Dmitry V. Duplyakov.
Aerodromnaya Street, 43, Samara; Chapaevskaya str., 89, Samara, 443099
Competing Interests:
None
D. V. Pevzner
Chazov National Medical Research Center of Cardiology
Russian Federation
Competing Interests:
Russian Federation
Dmitry V. Pevzner.
Academician Chazov str., 15A, Moscow, 121552
Competing Interests:
None
K. G. Pereverzeva
Ryazan State Medical University
Russian Federation
Competing Interests:
Russian Federation
Kristina G. Pereverzeva.
Vysokovoltnaya str., 9, Ryazan, 390026
Competing Interests:
None
References
1. Averkov OV, Arutyunyan GK, Duplyakov DV, et al. 2024 Clinical practice guidelines for Acute myocardial infarction with ST segment elevation electrocardiogram. Russian Journal of Cardiology. 2025;30(3):6306. (In Russ.) doi:10.15829/1560-4071-2025-6306. EDN: IVJCUK.
2. Averkov OV, Arutyunyan GK, Duplyakov DV, et al. 2024 Clinical practice guidelines for Acute coronary syndrome without ST segment elevation electrocardiogram. Russian Journal of Cardiology. 2025;30(5):6319. (In Russ.) doi:10.15829/1560-4071-2025-6319. EDN: CXJUIB.
3. Galyavich AS, Tereshchenko SN, Uskach TM, et al. 2024 Clinical practice guidelines for Chronic heart failure. Russian Journal of Cardiology. 2024;29(11):6162. (In Russ.) doi:10.15829/1560-4071-2024-6162. EDN: WKIDLJ.
4. Ali AS, Rybicki BA, Alam M, et al. Clinical predictors of heart failure in patients with first acute myocardial infarction. Am Heart J. 1999;138(6 Pt 1):1133-9. doi:10.1016/s0002-8703(99)70080-3.
5. Shah RV, Holmes D, Anderson M, et al. Risk of heart failure complication during hospitalization for acute myocardial infarction in a contemporary population: insights from the National Cardiovascular Data ACTION Registry. Circ Heart Fail. 2012;5(6):693-702. doi:10.1161/CIRCHEARTFAILURE.112.968180.
6. Steg PG, Dabbous OH, Feldman LJ, et al. Determinants and prognostic impact of heart failure complicating acute coronary syndromes: observations from the Global Registry of Acute Coronary Events (GRACE). Circulation. 2004;109(4):494-9. doi:10.1161/01.CIR.0000109691.16944.DA.
7. Desta L, Jernberg T, Löfman I, et al. Incidence, temporal trends, and prognostic impact of heart failure complicating acute myocardial infarction. The SWEDEHEART registry (Swedish web-system for enhancement and development of evidence-based care in heart disease evaluated according to recommended therapies): a study of 199,851 patients admitted with index acute myocardial infarctions, 1996 to 2008. JACC Heart Fail. 2015;3(3):234-42. doi:10.1016/j.jchf.2014.10.007.
8. Butler J, Hammonds K, Talha KM, et al. Incident heart failure and recurrent coronary events following acute myocardial infarction. Eur Heart J. 2025;46(16):1540-50. doi:10.1093/eurheartj/ehae885.
9. Wohlfahrt P, Jenča D, Melenovský V, et al. Trajectories and determinants of left ventricular ejection fraction after the first myocardial infarction in the current era of primary coronary interventions. Front Cardiovasc Med. 2022;9:1051995. doi:10.3389/fcvm.2022.1051995.
10. Torabi A, Cleland JG, Rigby AS, et al. Development and course of heart failure after a myocardial infarction in younger and older people. J Geriatr Cardiol. 2014;11(1): 1-12. EDN: YERVDF.
11. Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145(18):e895-e1032. doi:10.1161/CIR.0000000000001063.
12. McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599-726. doi:10.1093/eurheartj/ehab368.
13. Kim HY, Kim KH, Lee N, et al. Timing of heart failure development and clinical outcomes in patients with acute myocardial infarction. Front Cardiovasc Med. 2023;10:1193973. doi:10.3389/fcvm.2023.1193973.
14. Hohnloser SH, Kuck KH, Dorian P, et al. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med. 2004;351(24):2481-8. doi:10.1056/NEJMoa041489.
15. Armstrong PW, Pieske B, Anstrom KJ, et al. Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction. N Engl J Med. 2020;382(20):1883-93. doi:10.1056/NEJMoa1915928.
16. Solomon SD, McMurray JJV, Anand IS, et al. Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction. N Engl J Med. 2019;381(17):1609-20. doi:10.1056/NEJMoa1908655.
17. McMurray JJV, Solomon SD, Inzucchi SE, et al. Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction. N Engl J Med. 2019;381(21):1995-2008. doi:10.1056/NEJMoa1911303.
18. Packer M, Anker SD, Butler J, et al. Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure. N Engl J Med. 2020;383(15):1413-24. doi:10.1056/NEJMoa2022190.
19. Anker SD, Butler J, Filippatos G, et al. Empagliflozin in Heart Failure with a Preserved Ejection Fraction. N Engl J Med. 2021;385(16):1451-61. doi:10.1056/NEJMoa2107038.
20. Alpert JS, Thygesen K, Antman E, et al. Myocardial infarction redefined — a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol. 2000;36(3):959-69. doi:10.1016/s0735-1097(00)00804-4.
21. Thygesen K, Alpert JS, Jaffe AS, et al. Fourth Universal Definition of Myocardial Infarction (2018). Circulation. 2018;138(20):e618-e651. doi:10.1161/CIR.0000000000000617.
22. Thygesen K, Alpert JS, Jaffe AS, et al. Third universal definition of myocardial infarction. Eur Heart J. 2012;33(20):2551-67. doi:10.1093/eurheartj/ehs184.
23. Ghafoor M, Kamal M, Nadeem U, et al. Educational Case: Myocardial Infarction: Histopathology and Timing of Changes. Acad Pathol. 2020;7:2374289520976639. doi:10.1177/2374289520976639.
24. Prabhu SD, Frangogiannis NG. The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis. Circulation Research. 2016;119(1):91-112. doi:10.1161/CIRCRESAHA.116.303577.
25. Bostan MM, Stătescu C, Anghel L, et al. Post-Myocardial Infarction Ventricular Remodeling Biomarkers-The Key Link between Pathophysiology and Clinic. Biomolecules. 2020;10(11):1587. doi:10.3390/biom10111587.
26. Goodwin NP, Clare RM, Harrington JL, et al. Morbidity and Mortality Associated With Heart Failure in Acute Coronary Syndrome: A Pooled Analysis of 4 Clinical Trials. J Card Fail. 2023;29(12):1603-14. doi:10.1016/j.cardfail.2023.07.004.
Review
For citations:
Yakushin S.S., Barbarash O.L., Mareev V.Yu., Duplyakov D.V., Pevzner D.V., Pereverzeva K.G. Application of new guidelines for diagnosing heart failure after myocardial infarction: opinion on a problem. Russian Journal of Cardiology. 2026;31(3):6756. (In Russ.) https://doi.org/10.15829/1560-4071-2026-6756. EDN: YLTJCM
Views:
89
JATS XML
Email this article 